[1]
2026. Design and Evaluation of Mesalamine-Loaded Nanospheres for SIte-Specific drug delivery in ulcerative colitis treatment. Current Trends in Medicine and Clinical Research. 2, 1 (Apr. 2026). DOI:https://doi.org/10.5281/zenodo.19921487.